Cargando…

KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis

OBJECT: Interstitial lung disease (ILD) is a specific form of chronic fibrosing interstitial pneumonia with various etiology. The severity and progression of ILD usually predict the poor outcomes of ILD. Otherwise, Krebs von den Lungen-6 (KL-6) is a potential immunological biomarker reflecting the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tao, Shen, Ping, Duan, Chunyan, Gao, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699527/ https://www.ncbi.nlm.nih.gov/pubmed/34956179 http://dx.doi.org/10.3389/fimmu.2021.745233

Ejemplares similares

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
por: Jehn, Lutz B., et al.
Publicado: (2023)

Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases
por: Tagami, Yoichi, et al.
Publicado: (2021)

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
por: Lee, Jeong Seok, et al.
Publicado: (2019)

Correlation between CT Score and KL-6: A Severity Assessing in Juvenile Dermatomyositis Associated Interstitial Lung Disease
por: Wang, Chi, et al.
Publicado: (2023)

The Diagnostic Value of the Interstitial Biomarkers KL-6 and SP-D for the Degree of Fibrosis in Combined Pulmonary Fibrosis and Emphysema
por: Chiba, Shigeki, et al.
Publicado: (2012)

Expression of S100A9 and KL-6 in common interstitial lung diseases
por: Lin, Li, et al.
Publicado: (2022)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
por: Park, Hwa Kyung, et al.
Publicado: (2023)

Prognostic role of blood KL-6 in rheumatoid arthritis–associated interstitial lung disease
por: Kim, Ho Cheol, et al.
Publicado: (2020)

KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case–Control Study
por: Chiu, Yu-Hsiang, et al.
Publicado: (2022)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
por: Ye, Lifang, et al.
Publicado: (2022)

Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019
por: Awano, Nobuyasu, et al.
Publicado: (2020)

Blood KL-6 predicts prognosis in primary Sjögren’s syndrome-associated interstitial lung disease
por: Kim, Yun Jae, et al.
Publicado: (2022)

Peak value of serum KL-6 may be useful for predicting poor prognosis of severe COVID-19 patients
por: Maruyama, Shuhei, et al.
Publicado: (2022)

Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease
por: Wang, Yukai, et al.
Publicado: (2020)

Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients
por: Fan, Qinghong, et al.
Publicado: (2022)

KL-6 levels in the connective tissue disease population: typical values and potential confounders–a retrospective, real-world study
por: Zhou, Aiyuan, et al.
Publicado: (2023)

KL-6 levels in COVID-19
por: Scarpati, G, et al.
Publicado: (2020)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Recombination Drives Evolution of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 KL47 to KL64 in China
por: Chen, Tao, et al.
Publicado: (2023)

Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease
por: Wei, Fengqin, et al.
Publicado: (2023)

Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population
por: Zheng, Muhan, et al.
Publicado: (2021)

Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Morrison, Hazel, et al.
Publicado: (2021)

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
por: Huang, Da, et al.
Publicado: (2022)

KL-6 in ARDS and COVID-19 Patients
por: Piazza, Ornella, et al.
Publicado: (2022)

Digital Clubbing Is Associated with Higher Serum KL-6 Levels and Lower Pulmonary Function in Patients with Interstitial Lung Disease
por: Shiraishi, Kazushige, et al.
Publicado: (2018)

Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features
por: Wang, Jingxian, et al.
Publicado: (2020)

Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
por: Gagiannis, Daniel, et al.
Publicado: (2020)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report
por: Yonenaga, Yoshikuni, et al.
Publicado: (2021)

Pirfenidone inhibits cell fibrosis in connective tissue disease-associated interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway
por: Zuo, Yanhua, et al.
Publicado: (2022)

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2023)

Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
por: Bergantini, Laura, et al.
Publicado: (2019)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

Roles for the FCRL6 Immunoreceptor in Tumor Immunology
por: Davis, Randall S.
Publicado: (2020)

Keynote Lectures (KL)
Publicado: (2017)

Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease
por: Kawase, Shigeo, et al.
Publicado: (2011)

Diagnostic and prognostic predictive values of circulating KL-6 for interstitial lung disease: A PRISMA-compliant systematic review and meta-analysis
por: Zhang, Hongying, et al.
Publicado: (2020)

Editorial: Immunology of HPV Infection and Vaccination: Progress and Challenges
por: Licciardi, Paul V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rfsibkrtjlqmcqt9itkcvht930